Hanneke W. M. van Laarhoven

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · Journal of Clinical Oncology · 2021 · 772 citations · Full text

Medicine, Oncology, Surgery +17

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)

Maarten C.C.M. Hulshof, Elisabeth D. Geijsen, Tom Rozema et al. · Journal of Clinical Oncology · 2021 · 298 citations · Full text

Medicine, Oncology, Radiation Oncology +11

ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer

Praneeth R. Kuninty, Ruchi Bansal, Susanna W.L. de Geus et al. · Science Advances · 2019 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol

Bo Jan Noordman, Joël Shapiro, Manon C.W. Spaander et al. · JMIR Research Protocols · 2015 · 77 citations · Full text

Medicine, Oncology, Surgery +17

The role of hospital nurses in shared decision‐making about life‐prolonging treatment: A qualitative interview study

Danique W. Bos – van den Hoek, Maureen Thodé, Irene P. Jongerden et al. · Journal of Advanced Nursing · 2020 · 67 citations · Full text

Nursing, Palliative Nursing, End-of-life Care +16